Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,658 | 49 | 99.6% |
| Education | $16.30 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,620 | 19 | $0 (2024) |
| Boston Scientific Corporation | $444.96 | 12 | $0 (2024) |
| Daiichi Sankyo Inc. | $226.44 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $214.17 | 3 | $0 (2020) |
| Janssen Biotech, Inc. | $208.44 | 2 | $0 (2024) |
| Medtronic, Inc. | $182.25 | 1 | $0 (2023) |
| Exact Sciences Corporation | $181.51 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $155.07 | 3 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $136.37 | 2 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $128.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $864.59 | 9 | ABBVIE INC. ($235.98) |
| 2023 | $680.39 | 10 | Medtronic, Inc. ($182.25) |
| 2022 | $760.33 | 11 | ABBVIE INC. ($559.38) |
| 2021 | $519.11 | 7 | AbbVie Inc. ($356.39) |
| 2020 | $527.61 | 5 | AbbVie Inc. ($228.27) |
| 2019 | $141.56 | 3 | Gilead Sciences, Inc. ($115.13) |
| 2018 | $13.97 | 1 | AbbVie, Inc. ($13.97) |
| 2017 | $166.78 | 4 | Daiichi Sankyo Inc. ($124.92) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: EXALT_ENDO | ||||||
| 11/05/2024 | Boston Scientific Corporation | Advanix Biliary (Device) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Advanix_ENDO | ||||||
| 10/17/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $138.78 | General |
| Category: EXALT_ENDO | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $117.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $128.35 | General |
| Category: Rare Disease | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $118.37 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $107.78 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $83.48 | General |
| Category: Immunology | ||||||
| 11/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $73.73 | General |
| Category: Oncology | ||||||
| 10/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $124.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/12/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: EXALT_ENDO | ||||||
| 10/11/2023 | Stryker Corporation | STRYKER (Device) | Food and Beverage | In-kind items and services | $41.55 | General |
| Category: SURGICAL | ||||||
| 10/06/2023 | Stryker Corporation | STRYKER (Device) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: SURGICAL | ||||||
| 07/20/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: EXALT Model D_ENDO | ||||||
| 06/15/2023 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $182.25 | General |
| Category: Motility Testing | ||||||
| 05/24/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $81.88 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2023 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $100.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/04/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: EXALT_ENDO | ||||||
| 12/17/2022 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: EXALT_ENDO | ||||||
| 12/12/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $117.65 | General |
| 08/17/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $107.53 | General |
| Category: VIROLOGY | ||||||
| 05/31/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $121.28 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Education | In-kind items and services | $16.30 | General |
| Category: Neuroscience | ||||||
| 04/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $108.32 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 543 | 603 | $230,211 | $51,203 |
| 2022 | 11 | 431 | 472 | $217,405 | $40,509 |
| 2021 | 10 | 448 | 458 | $260,719 | $57,524 |
| 2020 | 12 | 643 | 689 | $329,351 | $73,952 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 160 | 164 | $70,588 | $16,673 | 23.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 170 | $37,787 | $10,625 | 28.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 62 | 62 | $29,857 | $5,424 | 18.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 51 | 51 | $29,817 | $4,769 | 16.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $23,497 | $4,685 | 19.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 59 | 64 | $8,184 | $2,536 | 31.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 11 | 11 | $9,633 | $2,046 | 21.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $9,904 | $1,804 | 18.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 21 | 22 | $8,004 | $1,510 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 15 | $2,940 | $1,130 | 38.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 111 | 114 | $58,140 | $12,151 | 20.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 75 | 75 | $46,725 | $6,570 | 14.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 108 | $29,160 | $6,215 | 21.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $20,900 | $3,088 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 20 | 20 | $6,900 | $2,273 | 32.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 11 | 11 | $12,628 | $2,203 | 17.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $11,571 | $2,049 | 17.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $12,656 | $1,824 | 14.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 38 | 46 | $7,365 | $1,482 | 20.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 13 | $5,082 | $1,099 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 11 | $2,288 | $887.08 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $3,990 | $667.36 | 16.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 96 | $27,360 | $9,352 | 34.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 115 | 118 | $73,514 | $9,187 | 12.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 50 | 50 | $44,522 | $7,535 | 16.9% |
About Dr. Dmitry Mysh, MD
Dr. Dmitry Mysh, MD is a Gastroenterology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033105903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dmitry Mysh, MD has received a total of $3,674 in payments from pharmaceutical and medical device companies, with $864.59 received in 2024. These payments were reported across 50 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($3,658).
As a Medicare-enrolled provider, Mysh has provided services to 2,065 Medicare beneficiaries, totaling 2,222 services with total Medicare billing of $223,189. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Fort Myers, FL
- Active Since 09/26/2005
- Last Updated 03/30/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1033105903
Products in Payments
- SKYRIZI (Biological) $304.85
- MAVYRET (Drug) $284.37
- EXALT Model D (Device) $238.18
- HUMIRA (Biological) $230.02
- RINVOQ (Biological) $229.60
- TREMFYA (Drug) $208.44
- Epclusa (Drug) $201.57
- ENDOFLIP (Device) $182.25
- Cologuard Collection Kit (Device) $181.51
- ZEPOSIA (Drug) $155.07
- IQIRVO (Drug) $128.35
- GATTEX (Drug) $124.92
- Movantik (Drug) $124.92
- LINZESS (Drug) $117.61
- XELJANZ (Drug) $108.16
- ORCAPOD (Device) $104.74
- INJECTAFER (Drug) $101.52
- CREON (Drug) $100.09
- STRYKER (Device) $68.42
- Humira (Biological) $58.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Myers
Randall Jacobs, Md, MD
Gastroenterology — Payments: $18,306
Juan Tejada-Almonte, M.d, M.D
Gastroenterology — Payments: $13,404
Dr. Augustine Salami, Md, MD
Gastroenterology — Payments: $10,902
Dr. Edward Jurkovic, D.o, D.O
Gastroenterology — Payments: $9,721
Robert Janda, Md, MD
Gastroenterology — Payments: $8,904
David Elliott, Do, DO
Gastroenterology — Payments: $8,680